Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Neuropharmacology. 2010 Dec 23;60(7-8):1262–1268. doi: 10.1016/j.neuropharm.2010.12.018

Figure 2.

Figure 2

Percent correct responses on each delay in Task 1 (squares) and Task 2 (circles) during baseline (filled symbols) and after huperzine A administration (open symbols). Within-subject analysis of variance with repeated measures indicated no significant effects of treatment, delay, or interaction between these two factors for either Task 1 or Task 2 (all ps>0.05).